TY - JOUR AU - Banholzer, M. L. AU - Buergin, H. AU - Wandel, C. AU - Schmitt, G. AU - Gocke, E. AU - Peck, R. PY - 2012 DA - 2012// TI - Clinical trial considerations on male contraception and collection of pregnancy information from female partners JO - J Transl Med VL - 10 UR - https://doi.org/10.1186/1479-5876-10-129 DO - 10.1186/1479-5876-10-129 ID - Banholzer2012 ER - TY - STD TI - ICH M7 (2014) Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_Step_4.pdf. Accessed 15 Jan 2016 UR - http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M7/M7_Step_4.pdf ID - ref2 ER - TY - STD TI - Clinical Trial Facilitation Group (CTFG) (2014) Recommendations related to contraception and pregnancy testing in clinical trials http://www.hma.eu/fileadmin/dateien/Human_Medicines/01-About_HMA/Working_Groups/CTFG/2014_09_HMA_CTFG_Contraception.pdf. Accessed 15 Jan 2016 UR - http://www.hma.eu/fileadmin/dateien/Human_Medicines/01-About_HMA/Working_Groups/CTFG/2014_09_HMA_CTFG_Contraception.pdf ID - ref3 ER - TY - STD TI - US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2015) Assessment of male-mediated developmental risk for pharmaceuticals guidance for industry: guidance for industry (draft guidance). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM450627.pdf. Accessed 15 Jan 2016 UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM450627.pdf ID - ref4 ER - TY - JOUR AU - Committee, E. S. PY - 2011 DA - 2011// TI - Scientific opinion on genotoxicity testing strategies applicable to food and feed safety assessment JO - EFSA J VL - 9 UR - https://doi.org/10.2903/j.efsa.2011.2379 DO - 10.2903/j.efsa.2011.2379 ID - Committee2011 ER - TY - STD TI - ICH S2 (R1) (2011) Guidance on genotoxicity testing and data interpretation for pharmaceuticals intended for human use. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf. Accessed 15 Jan 2016 UR - http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf ID - ref6 ER - TY - STD TI - EMEA/CHMP/203927/2005 (2008) Committee for medicinal products for human use (CHMP): guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labeling ID - ref7 ER - TY - JOUR AU - Klemmt, L. AU - Scialli, A. R. PY - 2005 DA - 2005// TI - The transport of chemicals in semen JO - Birth Defects Res B Dev Reprod Toxicol VL - 74 UR - https://doi.org/10.1002/bdrb.20031 DO - 10.1002/bdrb.20031 ID - Klemmt2005 ER - TY - JOUR AU - Jacobson-Kram, D. AU - Jacobs, A. PY - 2005 DA - 2005// TI - Use of genotoxicity data to support clinical trials or positive genetox findings on a candidate pharmaceutical or impurity…. now what? JO - Int J Toxicol VL - 24 UR - https://doi.org/10.1080/10915810590952933 DO - 10.1080/10915810590952933 ID - Jacobson-Kram2005 ER - TY - JOUR AU - Guerard, M. AU - Baum, M. AU - Bitsch, A. AU - Eisenbrand, G. AU - Elhajouji, A. AU - Epe, B. PY - 2015 DA - 2015// TI - Assessment of mechanisms driving non-linear dose-response relationships in genotoxicity testing JO - Mutat Res Rev Mutat Res VL - 763 UR - https://doi.org/10.1016/j.mrrev.2014.11.001 DO - 10.1016/j.mrrev.2014.11.001 ID - Guerard2015 ER - TY - JOUR AU - Kirsch-Volders, M. AU - Bonassi, S. AU - Knasmueller, S. AU - Holland, N. AU - Bolognesi, C. AU - Fenech, M. F. PY - 2014 DA - 2014// TI - Commentary: critical questions, misconceptions and a road map for improving the use of the lymphocyte cytokinesis-block micronucleus assay for in vivo biomonitoring of human exposure to genotoxic chemicals-a HUMN project perspective JO - Mutat Res Rev Mutat Res VL - 759 UR - https://doi.org/10.1016/j.mrrev.2013.12.001 DO - 10.1016/j.mrrev.2013.12.001 ID - Kirsch-Volders2014 ER - TY - JOUR AU - Muller, L. AU - Gocke, E. AU - Lave, T. AU - Pfister, T. PY - 2009 DA - 2009// TI - Ethyl methanesulfonate toxicity in Viracept—a comprehensive human risk assessment based on threshold data for genotoxicity JO - Toxicol Lett VL - 190 UR - https://doi.org/10.1016/j.toxlet.2009.04.003 DO - 10.1016/j.toxlet.2009.04.003 ID - Muller2009 ER - TY - JOUR AU - Gocke, E. AU - Ballantyne, M. AU - Whitwell, J. AU - Muller, L. PY - 2009 DA - 2009// TI - MNT and MutaMouse studies to define the in vivo dose response relations of the genotoxicity of EMS and ENU JO - Toxicol Lett VL - 190 UR - https://doi.org/10.1016/j.toxlet.2009.03.021 DO - 10.1016/j.toxlet.2009.03.021 ID - Gocke2009 ER - TY - JOUR AU - Nau, H. PY - 1991 DA - 1991// TI - Pharmacokinetic considerations in the design and interpretation of developmental toxicity studies JO - Fundam Appl Toxicol VL - 16 UR - https://doi.org/10.1016/0272-0590(91)90104-C DO - 10.1016/0272-0590(91)90104-C ID - Nau1991 ER - TY - JOUR AU - Cooper, T. G. AU - Noonan, E. AU - Eckardstein, S. AU - Auger, J. AU - Baker, H. W. AU - Behre, H. M. PY - 2010 DA - 2010// TI - World Health Organization reference values for human semen characteristics JO - Hum Reprod Update VL - 16 UR - https://doi.org/10.1093/humupd/dmp048 DO - 10.1093/humupd/dmp048 ID - Cooper2010 ER - TY - JOUR AU - Moldoveanu, Z. AU - Huang, W. Q. AU - Kulhavy, R. AU - Pate, M. S. AU - Mestecky, J. PY - 2005 DA - 2005// TI - Human male genital tract secretions: both mucosal and systemic immune compartments contribute to the humoral immunity JO - J Immunol VL - 175 UR - https://doi.org/10.4049/jimmunol.175.6.4127 DO - 10.4049/jimmunol.175.6.4127 ID - Moldoveanu2005 ER - TY - JOUR AU - Politch, J. A. AU - Tucker, L. AU - Bowman, F. P. AU - Anderson, D. J. PY - 2007 DA - 2007// TI - Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men JO - Hum Reprod VL - 22 UR - https://doi.org/10.1093/humrep/dem281 DO - 10.1093/humrep/dem281 ID - Politch2007 ER - TY - JOUR AU - Raux, M. AU - Finkielsztejn, L. AU - Salmon-Ceron, D. AU - Bouchez, H. AU - Excler, J. L. AU - Dulioust, E. PY - 1999 DA - 1999// TI - Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects JO - AIDS Res Hum Retroviruses VL - 15 UR - https://doi.org/10.1089/088922299310070 DO - 10.1089/088922299310070 ID - Raux1999 ER - TY - JOUR AU - Sohn, W. AU - Lee, E. AU - Kankam, M. K. AU - Egbuna, O. AU - Moffat, G. AU - Bussiere, J. PY - 2015 DA - 2015// TI - An open-label study in healthy men to evaluate the risk of seminal fluid transmission of denosumab to pregnant partners JO - Br J Clin Pharmacol ID - Sohn2015 ER - TY - JOUR AU - Kuo, P. Y. AU - Sherwood, J. K. AU - Saltzman, W. M. PY - 1998 DA - 1998// TI - Topical antibody delivery systems produce sustained levels in mucosal tissue and blood JO - Nat Biotechnol VL - 16 UR - https://doi.org/10.1038/nbt0298-163 DO - 10.1038/nbt0298-163 ID - Kuo1998 ER - TY - JOUR AU - Sherwood, J. K. AU - Zeitlin, L. AU - Chen, X. AU - Whaley, K. J. AU - Cone, R. A. AU - Saltzman, W. M. PY - 1996 DA - 1996// TI - Residence half-life of IgG administered topically to the mouse vagina JO - Biol Reprod VL - 54 UR - https://doi.org/10.1095/biolreprod54.1.264 DO - 10.1095/biolreprod54.1.264 ID - Sherwood1996 ER - TY - JOUR AU - Moffat, G. J. AU - Davies, R. AU - Kwon, G. AU - Retter, M. W. AU - Chellman, G. J. AU - Kanapuram, S. PY - 2014 DA - 2014// TI - Investigation of maternal and fetal exposure to an IgG2 monoclonal antibody following biweekly intravaginal administration to cynomolgus monkeys throughout pregnancy JO - Reprod Toxicol VL - 48 UR - https://doi.org/10.1016/j.reprotox.2014.05.003 DO - 10.1016/j.reprotox.2014.05.003 ID - Moffat2014 ER - TY - JOUR AU - Scialli, A. R. AU - Bailey, G. AU - Beyer, B. K. AU - Bogh, I. B. AU - Breslin, W. J. AU - Chen, C. L. PY - 2015 DA - 2015// TI - Potential seminal transport of pharmaceuticals to the conceptus JO - Reprod Toxicol VL - 58 UR - https://doi.org/10.1016/j.reprotox.2015.10.015 DO - 10.1016/j.reprotox.2015.10.015 ID - Scialli2015 ER - TY - JOUR AU - Cicinelli, E. AU - Ziegler, D. PY - 1999 DA - 1999// TI - Transvaginal progesterone: evidence for a new functional ‘portal system’ flowing from the vagina to the uterus JO - Hum Reprod Update VL - 5 UR - https://doi.org/10.1093/humupd/5.4.365 DO - 10.1093/humupd/5.4.365 ID - Cicinelli1999 ER - TY - JOUR AU - Mizutani, T. AU - Nishiyama, S. AU - Amakawa, I. AU - Watanabe, A. AU - Nakamuro, K. AU - Terada, N. PY - 1995 DA - 1995// TI - Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository JO - Fertil Steril VL - 63 UR - https://doi.org/10.1016/S0015-0282(16)57594-3 DO - 10.1016/S0015-0282(16)57594-3 ID - Mizutani1995 ER - TY - JOUR AU - Hui, J. Y. AU - Hoffmann, M. AU - Kumar, G. PY - 2014 DA - 2014// TI - Embryo-fetal exposure and developmental outcome of thalidomide following oral and intravaginal administration to pregnant rabbits JO - Reprod Toxicol VL - 48 UR - https://doi.org/10.1016/j.reprotox.2014.05.002 DO - 10.1016/j.reprotox.2014.05.002 ID - Hui2014 ER - TY - STD TI - US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) (2005) Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers ID - ref27 ER - TY - BOOK AU - Macdougall, J. PY - 2006 DA - 2006// TI - Analysis of dose–response studies—Emax model. Dose finding in drug development PB - Springer CY - New York, USA UR - https://doi.org/10.1007/0-387-33706-7_9 DO - 10.1007/0-387-33706-7_9 ID - Macdougall2006 ER - TY - JOUR AU - Lau, A. H. AU - Lam, N. P. AU - Piscitelli, S. C. AU - Wilkes, L. AU - Danziger, L. H. PY - 1992 DA - 1992// TI - Clinical pharmacokinetics of metronidazole and other nitroimidazole anti-infectives JO - Clin Pharmacokinet VL - 23 UR - https://doi.org/10.2165/00003088-199223050-00002 DO - 10.2165/00003088-199223050-00002 ID - Lau1992 ER - TY - JOUR AU - Levinson, R. S. AU - Mitan, S. J. AU - Steinmetz, J. I. AU - Gattermeir, D. J. AU - Schumacher, R. J. AU - Joffrion, J. L. PY - 2005 DA - 2005// TI - An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations JO - Clin Ther VL - 27 UR - https://doi.org/10.1016/j.clinthera.2005.12.006 DO - 10.1016/j.clinthera.2005.12.006 ID - Levinson2005 ER -